Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
Want to compare other data? Select Fields| Symbol | AKBA | AERI | ODT | ||
| Company | Akebia Therapeutics | Aerie Pharmaceuticals | Odonate Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 8.59 | 22.52 | 29.25 | ||
| High | 8.64 | 22.59 | 29.33 | ||
| Low | 7.60 | 21.24 | 28.05 | ||
| Last | 7.93 | 21.50 | 28.98 | ||
| Change | -0.64 | -1.06 | -0.07 | ||
| % Change | -7.47% | -4.70% | -0.24% | ||
| Volume | 1,467,300 | 1,563,700 | 59,100 | ||
| 20-Day Average Volume | 1,443,230 | 867,925 | 92,720 | ||
| Previous Close | 8.57 | 22.56 | 29.05 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 7.16 | 23.90 | 29.28 | ||
| 20-Day Raw Stochastic | 68.23% | 5.27% | 36.86% | ||
| 20-Day Relative Strength | 64.34% | 44.56% | 46.73% | ||
| Weighted Alpha | +12.20 | -49.00 | +29.30 | ||
| Today's Opinion | 100% Buy | 40% Sell | 56% Sell | ||
| Previous Opinion | 100% Buy | Hold | 56% Sell | ||
| Last Month's Opinion | 72% Buy | 8% Sell | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.93% since 01/16/20 | -10.83% since 01/16/20 | unch since 01/16/20 | ||
| Low | 7.60 on 01/24/20 | 21.24 on 01/24/20 | 26.37 on 01/22/20 | ||
| High | 8.74 on 01/23/20 | 24.27 on 01/17/20 | 29.70 on 01/17/20 | ||
| 1-Month | |||||
| %Chg | +17.83% since 12/24/19 | -14.34% since 12/24/19 | -4.10% since 12/24/19 | ||
| Low | 6.19 on 01/02/20 | 21.24 on 01/24/20 | 26.37 on 01/22/20 | ||
| High | 8.74 on 01/23/20 | 26.26 on 01/09/20 | 33.45 on 12/31/19 | ||
| 3-Month | |||||
| %Chg | +104.91% since 10/24/19 | +3.39% since 10/24/19 | -4.04% since 10/24/19 | ||
| Low | 2.99 on 11/13/19 | 17.15 on 11/21/19 | 26.37 on 01/22/20 | ||
| High | 8.74 on 01/23/20 | 26.26 on 01/09/20 | 39.50 on 11/20/19 | ||
| 6-Month | |||||
| %Chg | +95.32% since 07/24/19 | -6.40% since 07/24/19 | -13.75% since 07/24/19 | ||
| Low | 2.99 on 11/13/19 | 17.15 on 11/21/19 | 23.76 on 10/02/19 | ||
| High | 8.74 on 01/23/20 | 26.26 on 01/09/20 | 43.75 on 08/02/19 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 943,218 | 995,901 | 929,794 | ||
| Shares Outstanding, K | 118,943 | 46,321 | 32,084 | ||
| Annual Sales | 207,740,000 | 24,180,000 | 0 | ||
| Annual Net Income | -143,590,000 | -232,570,000 | -88,960,000 | ||
| Last Quarter Sales | 91,980,000 | 18,540,000 | N/A | ||
| Last Quarter Net Income | -54,590,000 | -49,400,000 | N/A | ||
| 60-Month Beta | 1.77 | 0.53 | 1.77 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | N/A | N/A | ||
| Latest Earnings Date | 11/12/19 | 02/24/20 | 02/28/20 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||
